FTC:WATCH No. 551

September 25, 2000

FTC widens Rx drug investigation

The FTCs Competition Bureau has expanded its investigation of relationships between and among branded prescription drug manufacturers and their generic equivalents, FTC:WATCH has...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch